TXMD vs XYL · rev $1.6M vs P/E 27, rev $4.46B
TherapeuticsMD Inc (TXMD) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported TXMD revenue for 2026-06-30 was $1.6M. Net income was $250.0K. TXMD currently screens at market cap $13.7M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
TXMD currently screens at market cap $13.7M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the TXMD and XYL stock pages for the full models.
Not investment advice.